Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000078003-11-000011)

Filing Details

Accession Number:: 0000078003-11-000011
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-09-07 18:59:23
Reporting Period:: 2011-09-02

Filing Date:: 2011-09-07
Accepted Time:: 2011-09-07 18:59:23
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
902622	Icagen Inc	ICGN	Pharmaceutical Preparations (2834)	561785001

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
78003	Pfizer Inc	235 E 42Nd St New York NY 10017		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-09-02	4,617,045	$6.00	4,617,045	No	4	P	Indirect	by Eclipse Acquisition Corp

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	by Eclipse Acquisition Corp

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,067,015	Direct

Footnotes

Represents shares purchased (including approximately 688,100 shares subject to guarantees of delivery) by Eclipse Acquisition Corp. ("Purchaser"), a wholly-owned subsidiary of Pfizer Inc. ("Parent"), in a tender offer. These shares are owned directly by Purchaser and may also be deemed to be indirectly beneficially owned by Parent.
Includes 1,067,015 previously directly owned by Parent.